HES and Acute Kidney Injury in Adult Cardiac Surgery

NCT02445820 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 697

Last updated 2015-10-30

No results posted yet for this study

Summary

This study retrospectively assess the effect or using balanced hydroxyethyl sctarch (HES) 130/0.4 or a balanced crystalloid solution as a pump prime and for intraoperative fluid therapy on the risk of early acute postoperative kidney injury in adult cardiac surgery patients.

Conditions

  • Acute Kidney Injury After Adult Cardiac Surgery

Interventions

DRUG

HES

2500 mL of balanced HES 130/0.4

DRUG

Crystalloid

2500 mL of balanced crystalloid.

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-07-31
Completion
2015-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02445820 on ClinicalTrials.gov